Connecting Patients to Clinical Trials

Developing innovative technologies and media for facilitating patient recruitment

TrialX enables...

Patients

such as Cinda to find trials for herself and her loved ones

Search Trials

Investigators

such as Jennifer to complete her clinical trial recruitment on time

Upload Your Trial

Hospitals

such as the Cleveland Clinic to create a centralized trial listing and recruitment tool

Learn More

Non-profits

such as the MMRF to create awareness for research and trials

Learn More

Why customers love TrialX.

Innovative Technology

Developed using an award winning semantic technology that matches patients to trials using their full-clinical record and clinical trial inclusion/exclusion criteria. Recently, we developed another novel interactive question/answering technology (winner of the 2011 NCI/Health 2.0 Developer Challenge) that guides and connects patients to research site using live calls

Great User Experience

At TrialX, we develop tools that we'd like to use. We continually refine the user interface and the flow to make it even easier for our customers to do their tasks effectively.

Customer Service

We Listen. We listen to what our customers say and often we fix/add features even before they tell us. The secret sauce of our awesome customer service is that we also "listen" to DATA. We mine access logs, error logs to solve problems before they arise (sort of like the Minory Report!)

I have been very pleased with the recruitment effort of TrialX for my research studies. They have been very diligent in finding qualified subjects in a reasonable time frame. I would definitely recommend their services to clinical research sites.

Dr. Arthur Waldbaum MD
  • Recently I have experienced several disconcerting changes in my prescribed medication.  In one case, pills that were once thin and white were now thicker and green.  The bottle said that the medication was the same inside.  But was it?  What gives? The same thing happened to me twice in a two week span.  It would […]
  • How refreshing; a myeloma doc that gets involved and gives back.  Outstanding! BTN LiveBIG: IU professor goes the distance for myeloma By Laura Depta – BTN In his “day job,” Dr. Rafat Abonour is a professor of medicine and a researcher at Indiana University specializing in multiple myeloma, a rare blood cancer. But he’s also […]
  • [...]
  • Sorry for the delay.  Cure Talks (new name, updated site) has been under construction.  Click on the link below: http://www.curetalks.com/event/rsvp/More-can-Cure-Myeloma-Treatment-with-Dr-Gareth-Morgan-/75/ Then drop down under first large graphic and click on the “go” arrow on the right side to listen.  It’s worth the trouble! Cure Talks Director, Priya Menon, promises access will be easier next time.  […]
  • Last night’s Cure Talks broadcast was both encouraging and overwhelming.  Myeloma Institute of Research and Therapy (MIRT) Director, Dr. Gareth Morgan, spent a great deal of time discussing upcoming advances in myeloma therapy and diagnostics.  This wasn’t more of the same.  Dr. Morgan revealed a number of new, innovative approaches being initiated now in Arkansas. […]
  • I’ve very excited!  Yesterday my registration materials arrived for next month’s American Society of Hematology (ASH) annual meetings in San Francisco.  And like clockwork, researchers and pharmaceutical companies have started issuing press releases promoting presentations featuring clinical trial results to be presented there. Here are two early examples.  Keep in mind that a lot new […]
  • The next Cure Panel Talk Show Tuesday afternoon features Dr. Gareth Morgan.  This is a really big deal and a great get; Dr. Morgan was recently named at Dr. Barlogie’s replacement at the Myeloma Institute for Research and Therapy (MIRT) in Arkansas. Total Therapy and the possibility that it can cure some patients will be […]
  • I want to reassure so many of you that emailed and contacted me via Facebook that I’m OK.  But it’s a good thing I dropped everything and drove down to Mayo Clinic yesterday afternoon. It was an interesting experience.  Please note that if you’re going to live on an Island–even a large, accessible one like […]
  • Who ever thought hearing that I had skin cancer would be good news? Mayo Clinic dermatology resident, Dr. Stephanie Ortman, called me yesterday afternoon with results from the three biopsies she carefully took last week.  To review, Dr. Ortman removed tissue from three suspicious spots on my left side: on my cheek, my “other” cheek […]
  • He’s back!  My dear friend and spiritual leader, Danny Parker, has had a tough year.  After some subtle arm twisting, Danny agreed to share his experiences with our MMB readers: Thoughts from the Edge of Relapse Pat has been asking me in recent weeks to say something about my disappearance from the myeloma world.  Of […]
  • If you follow my blog, you know I’m excited about the possibility of smaller, more targeted and nimble foundations.  Here’s a wonderful example of how this works. I met Sarah Kaufman-Fink four or five years ago at a myeloma patient meeting in Boston.  At the time she was the youngest myeloma patient I had ever […]
  • As most myeloma patients have come to understand, few people know about myeloma, it is often misdiagnosed, and improving awareness can and will SAVE LIFE and help fund research.  We have few programs to improve awareness with Mambo for Myeloma one of the grassroots initiatives which either could take off and make a huge difference like the ALS ice bucket challenge or just fade away.  I look at these remarkab [...]
  • Doctors at Mayo Clinic, Jacksonville, biopsied three different spots today.  Good thing Dr. Roy pulled some strings to get me in so quickly! I should know which ones need further attention next week.  One was, “possibly melanoma.”  According to the attractive young resident that did the exam; an opinion that was shared by the attending. […]
  • Sometimes getting a consult isn’t easy.  I was diagnosed with melanoma in the fall of 2011.  A nurse admitted it was most likely a second cancer, a result of long term Revlimid use.  A compromised immune system and the Florida Sun don’t mix! I eventually had surgery, and a sizable portion of my left ear […]
  • Something concerning happened to me Sunday afternoon.  Pattie and I were driving together running errands.  I needed to turnaround on the main route into town and head back home. I thought that I was thinking ahead and paying attention.  U-turns are legal from most turn lanes in Florida.  This one was no exception.  But there […]
  • As I reported yesterday, an FDA committee has reviewed clinical trial results for the experimental myeloma drug, panobinostat.  Five of seven committee members voted not to recommend FDA approval. Apparently, the overriding concern was the number of patients that were forced to drop out of the Phase 3 PANORAMA1 clinical trial while using the drug.  […]
  • Apparently safety concerns caused five of seven Oncologic Drugs Advisory Committee (ODAC) members to recommend the FDA not approve Novartis’ new myeloma therapy, panobinostat. I believe the vote is only an advisory one; the FDA could still approve it.  And according to what I’ve seen so far, several of those voting “no” admitted it was […]
  • [...]
  • My readers know that I’m currently using pomalidomide (Pomalyst).  So I get lots of questions about when its best to use it and possible side effects. Here’s an excerpt from an article on OncLive that takes a look at POM from the perspective of three well known myeloma specialists, Dr. Noopur Raji, Dr Sagar Lonial […]
  • Here’s a research update; several different drug developments that may help us live longer and better: Osteros begins Phase I trial of MBC-11 to treat cancer-induced bone disease Pharmaceutical Business Review – October 29, 2014 Osteros Biomedica has started dosing the first group of patients in an open-label dose-escalation Phase I trial of its drug […]